SLA And SLActive Surfaces: Driving Osseointegration

Angle: surface science - how SLA and SLActive microtopography and hydrophilicity set the speed of early bone contact and the durability of long-term stability.

The Healing Wait That Costs Cases

A machined titanium surface looks clean in the catalog, and that is precisely the problem. A smooth, turned fixture sits in bone the way a polished pebble sits in wet sand - contact is minimal, the clot adheres weakly, and weeks pass before osteoblasts find a reason to stay. In soft posterior maxilla, in fresh extraction sockets, and in any site where the surgeon wants to shorten the arc from surgery to crown, a passive surface quietly dictates a long, cautious healing phase. Early failure in these sites is rarely a failure of the titanium alloy itself; it is a failure of the interface to recruit bone fast enough to outrun micro-motion. Patients feel the cost as months of waiting. Clinicians feel it as delayed loading, provisional discomfort, and the constant worry that a borderline site will not integrate at all. The body shape gets the credit when an implant holds. The surface decides whether it holds in time.

Microtopography and the Biological Cascade

Osseointegration does not begin on surgery day; it begins at the moment blood meets the surface, and the surface chemistry and topography set the tempo of every step that follows. SLA - sandblasted, large-grit, acid-etched - creates a rough, irregular microtopography on the titanium alloy body that multiplies the bone-implant contact area and presents pits and ridges at the scale cells actually read. Proteins adsorb onto this roughness within minutes, the fibrin clot anchors into the crevices instead of sliding off, and migrating osteoprogenitor cells find a surface that favors adhesion over rounding up and floating away. The result is higher bone-implant contact at conventional healing intervals and a stiffer interface against micro-motion during the fragile first weeks.

SLActive takes the same etched microtopography and changes the chemistry. By processing and storing the etched surface under saline rather than allowing it to air-dry and form a thick hydrocarbon layer, SLActive remains hydrophilic. Water spreads across the surface instead of beading up, blood serum wets it completely, and the clot forms closer and faster. This is not cosmetic wetting: a hydrophilic surface shortens the protein-adsorption and clot-retention steps, so osteoblast attachment and early bone apposition shift earlier on the timeline. The biological cascade is the same either way - hemostasis, inflammatory modulation, progenitor cell migration, osteoid deposition, mineralization - but SLActive compresses it. Where SLA delivers robust contact at the standard healing window, SLActive delivers usable contact sooner, which is exactly what borderline, compromised, or time-pressed sites need.

The taper and the surface work as a system. The tapered body condenses bone for primary stability; the SLA or SLActive surface converts that mechanical grip into biological fusion quickly enough that micro-motion never crosses the 150 micrometre threshold at which fibrous encapsulation begins.

Reading the Surface Offer

The system is not a single surface but a choice matched to the site. A machined or minimally treated finish, once the industry default, now survives mainly in narrow anterior restorations where soft-tissue management and a polished transmucosal collar matter more than speed. SLA is the workhorse surface across the diameter range - on the Ø3.5 mm narrow platform for thin ridges and lateral incisors, and on the Ø4.1, Ø4.7, and Ø5.3 mm regular platforms for premolars, molars, and multiple adjacent units. SLActive is the accelerated option reserved for the sites where time is the binding constraint: soft posterior bone, fresh extraction sockets, limited bone volume after ridge preservation, and any case where early or immediate loading is on the table. Collar heights of 7, 9, 11, 13, and 15 mm are independent of the surface choice, so the transmucosal margin can be placed at the tissue level regardless of whether SLA or SLActive is selected.

Choosing the Surface at the Treatment Plan

Surface selection should be settled before the first drill, not improvised at surgery. Ask three questions. First, what is the bone quality? Dense mandibular anterior bone integrates predictably on SLA; the soft posterior maxilla is where SLActive buys its margin. Second, what is the loading plan? A patient willing to wait the conventional healing interval is well served by SLA; a patient who demands an early provisional, or a full-arch protocol that depends on early loading, should be routed to SLActive. Third, how compromised is the site? A fresh socket, a narrow ridge handled with the Ø3.5 mm narrow platform, or a limited-depth site benefits from the faster early contact that hydrophilicity provides.

Once the surface is chosen, surgical technique has to protect it. The etched layer is delicate: excessive contact with metal instruments, repeated handling, or contamination by glove powder or saliva during placement degrades the very chemistry the surface was engineered for. Place the fixture with the final driver, minimize touches to the body, and seat at the controlled insertion speed that the tapered body and the osteotomy allow. The 35 Ncm tightening discipline on the prosthetic side is unchanged by surface choice; the surface governs biology, not the torque wrench. And because the SLActive surface is hydrophilic, handle it per the manufacturer's wet-storage protocol - exposure to air for too long before seating quietly erodes the advantage you selected it for.

What the Clinic Actually Sees

Patterns repeat across practices that use both surfaces. SLA cases heal to schedule and behave like mature, long-term integrated fixtures; the difference between SLA and a generation of older surfaces is felt mainly in how few late complications reach the recall list. SLActive cases are where the daily difference is visible: a posterior crown delivered earlier than the old healing calendar allowed, a fresh-socket site that did not need the second-stage delay the team planned for, and fewer anxious weeks for the patient. The narrow-platform Ø3.5 mm implant in the anterior aesthetic zone illustrates the point well - the aesthetic outcome depends on soft-tissue health, and soft tissue follows bone; an SLActive surface that reaches early bone contact faster gives the papilla and the emergence profile a stable foundation sooner.

The lesson from real use is that surface is a planning variable, not a default. Teams that treat SLA and SLActive as interchangeable leave the advantage on the table; teams that match the surface to bone quality and loading expectations report fewer surprises, shorter provisional phases, and a calmer patient journey.

Why the Surface Outlasts the Crown

It is easy to treat surface treatment as a coating, something applied at the end of manufacturing. It is not. The surface is the interface through which every load is transferred to bone, and the quality of that interface determines whether long-term stability is maintained or gradually lost. Roughness that favors early bone contact also favors sustained load distribution: the more the bone interlocks with the microtopography, the more evenly occlusal forces are spread and the less stress concentrates at any one point. On a titanium alloy body machined to exact thread geometry, an SLA or SLActive surface converts mechanical precision into biological permanence. The crown is replaced, the abutment is changed, but the bone-implant interface must remain intact for decades - and that is what the surface was engineered to guarantee.

The Direction of Surface Science

The field is moving toward surfaces that integrate even faster, that actively modulate the inflammatory phase instead of merely accepting it, and that resist bacterial colonization while favoring osteoblasts. Combinations of hydrophilic etching with bioactive or anodic modifications are already in development, and early-loading protocols will only widen as the evidence for accelerated contact accumulates. The practical recommendation is straightforward: treat the surface as a first-order planning decision alongside diameter, platform, and collar height. Match SLA to routine healed sites, reserve SLActive for compromised or time-critical ones, and protect the surface from the moment it leaves its package. The implant body has not changed much in ten years; the surface is where the next decade of progress will be written.